A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity
Clinical trial NCT01153815 · COMPLETED
Trial details
- NCT number
- NCT01153815
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-06-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.